Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.252 | 1.124 | 0.57879 | 1.00000 | |
RegionR2 | -0.075 | 1.124 | 0.87554 | 1.00000 | |
RegionR3 | -0.313 | 1.124 | 0.92517 | 1.00000 | |
RegionR4 | -1.521 | 1.124 | 0.99807 | 1.00000 | |
RegionR5 | -2.076 | 1.124 | 0.99943 | 1.00000 | |
RegionR6 | 1.498 | 1.124 | 0.14703 | 0.68435 | |
RegionR7 | 1.999 | 1.124 | 0.10674 | 0.62070 | |
RegionR8 | 3.74 | 1.124 | 0.00135 | 0.05737 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.221 | 1.124 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.805 | 1.124 | 0.37277 | 0.79739 | |
RegenerationR3 | 0.599 | 1.124 | 0.60904 | 0.91218 | |
RegenerationR4 | 0.122 | 1.124 | 0.91439 | 1.00000 | |
RegenerationR5 | -1.047 | 1.124 | 0.42119 | 0.81194 | |
RegenerationR6 | -4.95 | 1.124 | 0.00165 | 0.04518 | |
RegenerationBL | -5.588 | 1.124 | 0.01284 | 0.11639 | |
RegenerationTP | -3.084 | 1.124 | 0.03221 | 0.30138 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
2. | MligTC455_15449 | 384 | 7.99 | Mlig455_043360 | Neo: - Age: - |
2.579 | - | - | 0.954 | - | 0.886 | 0.739 | Mlig455_043360 {REF} {Length: 1602} {NoTransDecoderORF} {RNA1509_38319} {RNA1310_35989.1} {RNA815_36673} | |
3. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 1.916 | 0.933 | - | - | - | 0.983 | - | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
4. | MligTC455_46956 | 548 | 11.42 | Mlig455_033544 | Neo: - Age: Down-Up-Up Region-enriched R6: 2.145/0.00606 |
1.876 | 0.976 | - | - | - | 0.900 | - | Mlig455_033544 {REF} {Length: 1097} {RNA1509_43580} {RNA1310_52830, RNA1509_43580} {RNA1509_43580, RNA815_30284} | |
5. | MligTC455_49949 | 46 | 0.95 | Mlig455_069056 | Neo: - Age: - |
ASIC1 | 1.821 | - | - | 0.998 | - | - | 0.823 | Mlig455_069056 {REF} {Length: 2381} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.2, Expect=2e-08]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=76.6, Expect=2e-14]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=94.4, Expect=4e-20]} {RNA1509_44792} {RNA1310_8631} {RNA815_5782} |
6. | MligTC455_37794 | 20 | 0.42 | Mlig455_017854, Mlig455_047876 | Neo: - Age: - |
1.77 | - | - | 0.986 | 0.784 | - | - | Mlig455_017854 {REF} {Length: 3779} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_84895} {RNA815_39433} Mlig455_047876 {REF} {Length: 3089} {NoTransDecoderORF} {RNA1310_84895} |
|
7. | MligTC455_31212 | 97 | 2.02 | Mlig455_028599, Mlig455_056911 | Neo: - Age: - |
1.734 | - | - | - | 0.740 | 0.994 | - | Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} |
|
8. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.719 | - | - | 0.732 | - | - | 0.987 | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
9. | MligTC455_11862 | 13 | 0.26 | Mlig455_024721 | Neo: - Age: - |
DLG4 | 1.694 | - | - | 0.741 | - | - | 0.953 | Mlig455_024721 {REF} {Length: 1968} {Pfam: PDZ domain [PF00595.26, score=63.1]; PDZ domain [PF17820.3, score=49.6]; PDZ domain [PF13180.8, score=31.6]} {Human: ENSG00000132535, DLG4, discs large MAGUK scaffold protein 4, [Score=71.6, Expect=6e-14]; ENSG00000132849, PATJ, PATJ, crumbs cell polarity complex component, [Score=68.9, Expect=3e-12]} {Mouse: ENSMUSG00000016520, Lnx2, ligand of numb-protein X 2, [Score=71.6, Expect=2e-13]; ENSMUSG00000020886, Dlg4, discs large MAGUK scaffold protein 4, [Score=70.9, Expect=7e-14]} {Dmel: FBgn0263289, scrib, scribbled, [Score=69.7, Expect=7e-13]} {Celegans: WBGene00001006, dlg-1, Drosophila Discs LarGe homolog; MAGUK protein DLG-1; SAP97-like protein DLG-1, [Score=55.8, Expect=2e-08]} {Smed: dd_Smed_v6_8994_0_1, dd_Smed_v6_8994_0_1, [Score=104, Expect=7e-25]} {RNA1509_45931} {RNA1310_25435.2} {RNA815_1460.1} |
10. | MligTC455_17534 | 40 | 0.84 | Mlig455_004568 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.609/0.04169 |
1.692 | 0.728 | - | - | - | 0.964 | - | Mlig455_004568 {REF} {Length: 2000} {Pfam: CD20-like family [PF04103.17, score=25.6]} {RNA1509_45188} {RNA1310_19605, RNA1509_45188} {RNA1509_45188, RNA815_13393} | |
11. | MligTC455_21050 | 18 | 0.37 | Mlig455_024510 | Neo: - Age: - |
1.678 | - | - | - | - | 0.722 | 0.956 | Mlig455_024510 {REF} {Length: 2499} {RNA1310_68107} {RNA815_59638} | |
12. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
1.655 | - | - | - | - | 0.954 | 0.701 | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
13. | MligTC455_09686 | 4 | 0.08 | Mlig455_061629 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1} | |
14. | MligTC455_12355 | 27 | 0.56 | Mlig455_024618 | Neo: - Age: - |
CHRNA3 | 1 | - | - | 1.000 | - | - | - | Mlig455_024618 {REF} {Length: 2865} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=270.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=246.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [RH, Score=432, Expect=7e-146]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [RH, Score=432, Expect=5e-146]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [RH, Score=419, Expect=1e-140]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [RH, Score=427, Expect=6e-144]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [RH, Score=426, Expect=2e-143]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [RH, Score=418, Expect=1e-140]; ENSMUSG00000035200, Chrnb4, cholinergic receptor, nicotinic, beta polypeptide 4, [RH, Score=406, Expect=4e-136]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [RH, Score=524, Expect=0.0]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=459, Expect=4e-157]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [RH, Score=521, Expect=6e-180]} {RNA1509_36802} {RNA1310_50512} {RNA815_3014.1} |
15. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
16. | MligTC455_13493 | 28 | 0.58 | Mlig455_020299 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929} | |
17. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 1 | - | - | 1.000 | - | - | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
18. | MligTC455_15160 | 11 | 0.23 | Mlig455_024917 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042} | |
19. | MligTC455_18788 | 27 | 0.57 | Mlig455_040989, Mlig455_040991 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904} Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1} |
|
20. | MligTC455_36252 | 20 | 0.42 | Mlig455_050668 | Neo: - Age: - |
PRKAR2B | 1 | - | - | 1.000 | - | - | - | Mlig455_050668 {REF} {Length: 1234} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=45.2]} {Human: ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=93.2, Expect=7e-21]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=96.3, Expect=3e-22]} {Smed: dd_Smed_v6_1362_0_1, dd_Smed_v6_1362_0_1, [Score=87.8, Expect=2e-19]} |
21. | MligTC455_05874 | 5 | 0.11 | Mlig455_049976 | Neo: - Age: - |
0.998 | - | - | 0.998 | - | - | - | Mlig455_049976 {REF} {Length: 389} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109621} | |
22. | MligTC455_41297 | 10 | 0.21 | Mlig455_015247 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_015247 {REF} {Length: 738} {NoTransDecoderORF} | |
23. | MligTC455_41475 | 43 | 0.89 | Mlig455_021663, Mlig455_021712 | Neo: - Age: - |
0.998 | - | - | 0.998 | - | - | - | Mlig455_021663 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_96898} Mlig455_021712 {REF} {Length: 812} {NoTransDecoderORF} {RNA1310_96898} |
|
24. | MligTC455_49878 | 31 | 0.65 | Mlig455_050656 | Neo: - Age: - |
CHRNA10 | 0.997 | - | - | - | - | 0.997 | - | Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952} |
25. | MligTC455_02461 | 5 | 0.11 | Mlig455_019900 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} | |
26. | MligTC455_53285 | 6 | 0.13 | Mlig455_061305 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF} | |
27. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.991 | - | - | 0.991 | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
28. | MligTC455_18262 | 28 | 0.59 | Mlig455_023697 | Neo: - Age: Down-Up-Down |
0.991 | - | - | - | - | 0.991 | - | Mlig455_023697 {REF} {Length: 552} {NoTransDecoderORF} {RNA1509_11101} {RNA1310_22145} {RNA815_35811} | |
29. | MligTC455_21884 | 13 | 0.27 | Mlig455_070568 | Neo: - Age: - |
SRSF7 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_070568 {REF} {Length: 1659} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=59.7]; RNA recognition motif [PF16367.7, score=24.4]; Zinc knuckle [PF00098.25, score=20.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=19.2]} {Human: ENSG00000115875, SRSF7, serine and arginine rich splicing factor 7, [RH, Score=142, Expect=6e-43]} {Mouse: ENSMUSG00000024097, Srsf7, serine/arginine-rich splicing factor 7, [RH, Score=142, Expect=4e-43]} {Dmel: FBgn0260944, Rbp1, RNA-binding protein 1, [RH, Score=102, Expect=2e-27]} {Celegans: WBGene00004703, rsp-6, Probable splicing factor, arginine/serine-rich 6, [Score=103, Expect=7e-28]} {Smed: dd_Smed_v6_2424_0_1, dd_Smed_v6_2424_0_1, [RH, Score=124, Expect=4e-36]} {RNA1509_38744} {RNA1310_52982} {RNA815_7835} |
30. | MligTC455_30594 | 23 | 0.48 | Mlig455_038529, Mlig455_052221 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1} Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1} |
|
31. | MligTC455_09822 | 5 | 0.1 | Mlig455_017858 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_017858 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_73710} | |
32. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
33. | MligTC455_14578 | 33 | 0.69 | Mlig455_033066 | Neo: - Age: - |
0.989 | - | - | - | - | 0.989 | - | Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} | |
34. | MligTC455_23922 | 8 | 0.17 | Mlig455_001765 | Neo: - Age: Down-Up-Down |
0.989 | - | - | - | - | 0.989 | - | Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709} | |
35. | MligTC455_29464 | 25 | 0.53 | Mlig455_021892 | Neo: - Age: - |
SDCCAG8 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_021892 {REF} {Length: 3036} {Pfam: Centrosomal colon cancer autoantigen protein family [PF15964.7, score=164.7]} {Human: ENSG00000276111, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]; ENSG00000054282, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000026504, Sdccag8, serologically defined colon cancer antigen 8, [RH, Score=109, Expect=4e-24]} {Dmel: FBgn0266566, CG45105, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_9295_0_2, dd_Smed_v6_9295_0_2, [RH, Score=87.8, Expect=7e-18]} {RNA1509_42574} {RNA1310_5942.1} {RNA815_9353.1} |
36. | MligTC455_00524 | 6 | 0.12 | Mlig455_035116 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF} | |
37. | MligTC455_11476 | 26 | 0.54 | Mlig455_035212 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_035212 {REF} {Length: 1374} {RNA1310_88897} {RNA815_51066} | |
38. | MligTC455_39681 | 136 | 2.83 | Mlig455_045908, Mlig455_045958, Mlig455_063327 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.624 Region-enriched R2: 4.082/0.00717 |
CASP1, CASP7 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_045908 {REF} {Length: 1556} {NoTransDecoderORF} {RNA1310_115705} {RNA815_46116} Mlig455_045958 {REF} {Length: 1362} {Pfam: Caspase domain [PF00656.24, score=68.0]} {Human: ENSG00000165806, CASP7, caspase 7, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=58.9, Expect=1e-09]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=53.1, Expect=6e-08]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=49.7, Expect=4e-07]} {RNA1310_50397} {RNA815_46116} Mlig455_063327 {REF} {Length: 3941} {Pfam: Caspase domain [PF00656.24, score=81.3]} {Human: ENSG00000137752, CASP1, caspase 1, [Score=79.7, Expect=1e-15]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=82.8, Expect=1e-16]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=63.2, Expect=2e-10]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=75.9, Expect=6e-15]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=73.9, Expect=1e-14]} {RNA1509_50041} {RNA1310_2539.1} {RNA815_252.1} |
39. | MligTC455_06577 | 7 | 0.14 | Mlig455_044334 | Neo: - Age: Up-Down-Down |
0.987 | - | - | - | - | 0.987 | - | Mlig455_044334 {REF} {Length: 706} | |
40. | MligTC455_27078 | 22 | 0.46 | Mlig455_028337, Mlig455_066176 | Neo: - Age: - |
0.987 | - | - | 0.987 | - | - | - | Mlig455_028337 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} Mlig455_066176 {REF} {Length: 883} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} |
|
41. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
42. | MligTC455_32222 | 6 | 0.13 | Mlig455_068777 | Neo: - Age: Down-Up-Down |
0.986 | - | - | - | - | 0.986 | - | Mlig455_068777 {REF} {Length: 1563} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=55.5, Expect=1e-08]} {RNA1509_41917} {RNA1310_24082} {RNA815_13028} | |
43. | MligTC455_33913 | 32 | 0.66 | Mlig455_047326 | Neo: - Age: - |
SPON1 | 0.986 | - | - | 0.986 | - | - | - | Mlig455_047326 {REF} {Length: 2405} {Pfam: Spondin_N [PF06468.15, score=98.6]} {Human: ENSG00000262655, SPON1, spondin 1, [Score=117, Expect=1e-27]} {Mouse: ENSMUSG00000038156, Spon1, spondin 1, (f-spondin) extracellular matrix protein, [Score=115, Expect=4e-27]} {Dmel: FBgn0033710, CG17739, [Score=105, Expect=3e-24]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=83.6, Expect=5e-17]} {Smed: dd_Smed_v6_2400_0_1, dd_Smed_v6_2400_0_1, [Score=83.6, Expect=4e-17]} {RNA1509_30850} {RNA1310_29306} {RNA815_50316} |
44. | MligTC455_13471 | 12 | 0.26 | Mlig455_065390 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_065390 {REF} {Length: 665} {NoTransDecoderORF} {RNA1509_16969} {RNA1310_51432} {RNA815_47685} | |
45. | MligTC455_51820 | 83 | 1.72 | Mlig455_023927 | Neo: - Age: - |
TCAF2C | 0.985 | - | - | - | - | - | 0.985 | Mlig455_023927 {REF} {Length: 2841} {Pfam: Peptidase M60, enhancin and enhancin-like [PF13402.8, score=147.1]; N-terminal domain of M60-like peptidases [PF17291.4, score=51.5]} {Human: ENSG00000283528, TCAF2C, TRPM8 channel associated factor 2C, [RH, Score=297, Expect=2e-89]; ENSG00000170379, TCAF2, TRPM8 channel associated factor 2, [RH, Score=292, Expect=6e-86]} {Mouse: ENSMUSG00000029851, Tcaf2, TRPM8 channel-associated factor 2, [RH, Score=284, Expect=4e-83]} {Smed: dd_Smed_v6_13298_0_1, dd_Smed_v6_13298_0_1, [RH, Score=116, Expect=1e-26]} {RNA1509_48809} {RNA1310_14523, RNA1509_48809} {RNA1509_48809, RNA815_23113} |
46. | MligTC455_12203 | 8 | 0.17 | Mlig455_061049 | Neo: - Age: - |
0.984 | - | - | - | - | 0.984 | - | Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1} | |
47. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 0.984 | - | - | - | - | 0.984 | - | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
48. | MligTC455_42708 | 48 | 1.01 | Mlig455_027999, Mlig455_028026 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_027999 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} Mlig455_028026 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} |
|
49. | MligTC455_53286 | 6 | 0.13 | Mlig455_061308 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_061308 {REF} {Length: 398} {NoTransDecoderORF} | |
50. | MligTC455_19171 | 162 | 3.38 | Mlig455_047844 | Neo: - Age: - |
LRRD1 | 0.981 | - | - | - | - | 0.981 | - | Mlig455_047844 {REF} {Length: 3483} {Pfam: Leucine rich repeat [PF13855.8, score=200.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=161.9]; Leucine-rich repeat [PF14580.8, score=62.9]; Death domain [PF00531.24, score=25.2]; RsmF rRNA methyltransferase first C-terminal domain [PF17126.7, score=19.3]} {Human: ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [RH, Score=265, Expect=2e-76]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [RH, Score=305, Expect=1e-91]} {Dmel: FBgn0038504, Sur-8, [Score=157, Expect=3e-40]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=151, Expect=1e-38]} {Smed: dd_Smed_v6_10136_0_1, dd_Smed_v6_10136_0_1, [RH, Score=281, Expect=6e-85]} {RNA1509_11343, RNA1509_19633} {RNA1310_7039.2, RNA1509_11343} {RNA1509_11343, RNA815_1369.1} |
51. | MligTC455_24197 | 48 | 1 | Mlig455_062645 | Neo: - Age: - |
KCNH7 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448} |
52. | MligTC455_49870 | 86 | 1.8 | Mlig455_028362, Mlig455_067454, Mlig455_067455 | Neo: - Age: - |
CHRM1, CHRM4 | 0.98 | - | - | - | - | - | 0.980 | Mlig455_028362 {REF} {Length: 3223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=40.4]} {Human: ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=98.2, Expect=2e-21]; ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=94.7, Expect=3e-20]} {Mouse: ENSMUSG00000032773, Chrm1, cholinergic receptor, muscarinic 1, CNS, [Score=97.4, Expect=2e-21]; ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=94.7, Expect=2e-20]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [Score=136, Expect=5e-34]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [RH, Score=128, Expect=4e-33]} {Smed: dd_Smed_v6_37337_0_1, dd_Smed_v6_37337_0_1, [RH, Score=149, Expect=1e-42]} {RNA1310_12338} {RNA815_37088} Mlig455_067454 {REF} {Length: 1188} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=103.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.2]} {Human: ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=102, Expect=2e-23]; ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=97.1, Expect=1e-21]} {Mouse: ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=103, Expect=6e-24]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [Score=189, Expect=1e-53]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [Score=133, Expect=3e-34]} {Smed: dd_Smed_v6_24759_0_1, dd_Smed_v6_24759_0_1, [Score=225, Expect=7e-69]} {RNA1310_12338} {RNA815_52171} Mlig455_067455 {REF} {Length: 2697} {RNA1310_12338} {RNA815_37088} |
53. | MligTC455_07840 | 30 | 0.62 | Mlig455_036470 | Neo: - Age: - |
MCTP2 | 0.979 | 0.979 | - | - | - | - | - | Mlig455_036470 {REF} {Length: 1672} {Human: ENSG00000140563, MCTP2, multiple C2 and transmembrane domain containing 2, [Score=79.0, Expect=3e-15]} {Mouse: ENSMUSG00000032776, Mctp2, multiple C2 domains, transmembrane 2, [Score=79.7, Expect=1e-15]} {Celegans: WBGene00017063, mctp-1, Multiple C2 and Transmembrane region Protein family homolog, [Score=62.8, Expect=2e-10]} {RNA1310_26354} {RNA815_41833} |
54. | MligTC455_43084 | 5 | 0.11 | Mlig455_035337 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_035337 {REF} {Length: 1065} {Pfam: Lectin C-type domain [PF00059.23, score=29.5]} {Smed: dd_Smed_v6_38541_0_2, dd_Smed_v6_38541_0_2, [Score=47.0, Expect=2e-06]} {RNA1509_45080} {RNA1310_133134} | |
55. | MligTC455_43829 | 45 | 0.95 | Mlig455_008872, Mlig455_008973 | Neo: - Age: Down-Up-Up |
TLL1 | 0.979 | - | - | 0.979 | - | - | - | Mlig455_008872 {REF} {Length: 3395} {Pfam: CUB domain [PF00431.22, score=147.6]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=92.8, Expect=1e-18]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=91.3, Expect=3e-18]} {Dmel: FBgn0261262, CG42613, [Score=102, Expect=9e-22]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=79.0, Expect=9e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=265, Expect=1e-76]} {RNA1509_49507} {RNA1310_6026} {RNA815_27015} Mlig455_008973 {REF} {Length: 2985} {Pfam: CUB domain [PF00431.22, score=149.2]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=90.5, Expect=7e-18]; ENSG00000107611, CUBN, cubilin, [Score=86.3, Expect=2e-16]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=89.0, Expect=2e-17]} {Dmel: FBgn0261262, CG42613, [Score=101, Expect=1e-21]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=81.6, Expect=1e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=267, Expect=2e-77]} {RNA1509_49507, RNA1509_572} {RNA1310_6026, RNA1509_49507, RNA1509_572} {RNA1509_49507, RNA1509_572, RNA815_27015} |
56. | MligTC455_51123 | 37 | 0.77 | Mlig455_059507 | Neo: - Age: - |
0.979 | - | - | - | - | 0.979 | - | Mlig455_059507 {REF} {Length: 970} {RNA1310_88282} | |
57. | MligTC455_25152 | 168 | 3.51 | Mlig455_040072 | Neo: - Age: - Region-enriched R8: 4.101/0.00210 |
0.978 | - | - | - | - | - | 0.978 | Mlig455_040072 {REF} {Length: 2067} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=43.4]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.9]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=57.8, Expect=1e-09]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
58. | MligTC455_48125 | 91 | 1.9 | Mlig455_005602, Mlig455_070397 | Neo: - Age: - Region-enriched R2: 4.171/0.01740 |
0.978 | - | - | - | - | 0.978 | - | Mlig455_005602 {REF} {Length: 2407} {RNA1509_6760} {RNA1310_2628} {RNA815_4402} Mlig455_070397 {REF} {Length: 2447} {RNA1509_6760} {RNA1310_132399} {RNA815_4402} |
|
59. | MligTC455_13038 | 60 | 1.25 | Mlig455_044479 | Neo: - Age: - Region-enriched R6: 4.393/0.00410 |
0.977 | 0.977 | - | - | - | - | - | Mlig455_044479 {REF} {Length: 663} | |
60. | MligTC455_06009 | 10 | 0.21 | Mlig455_029013 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_029013 {REF} {Length: 278} {NoTransDecoderORF} {RNA1509_52207} {RNA1310_104907} {RNA815_61228} | |
61. | MligTC455_10303 | 18 | 0.37 | Mlig455_046266, Mlig455_061552 | Neo: - Age: Up-Down-Down |
0.976 | - | - | - | - | 0.976 | - | Mlig455_046266 {REF} {Length: 471} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408} Mlig455_061552 {REF} {Length: 293} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408} |
|
62. | MligTC455_52065 | 35 | 0.73 | Mlig455_043270, Mlig455_043296 | Neo: Int S/G2/M Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_043270 {REF} {Length: 1377} {NoTransDecoderORF} {RNA1310_78448} Mlig455_043296 {REF} {Length: 1020} {NoTransDecoderORF} {RNA1310_78448} |
|
63. | MligTC455_22841 | 20 | 0.41 | Mlig455_066350 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_066350 {REF} {Length: 694} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35987, RNA1509_46319} {RNA1310_35806, RNA1509_35987, RNA1509_46319} {RNA1509_35987, RNA1509_46319, RNA815_14596} | |
64. | MligTC455_00072 | 10 | 0.2 | Mlig455_001911 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_001911 {REF} {Length: 296} {NoTransDecoderORF} {RNA1310_118235} | |
65. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
66. | MligTC455_34185 | 16 | 0.34 | Mlig455_050312 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_050312 {REF} {Length: 3239} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=162.4]; Kringle domain [PF00051.20, score=19.3]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=48.5, Expect=1e-05]} {RNA1509_40323} {RNA1310_4383.1} {RNA815_40563} | |
67. | MligTC455_35426 | 27 | 0.55 | Mlig455_043708, Mlig455_043796, Mlig455_047447 | Neo: - Age: - Region-enriched R4: 3.107/0.04694 |
COG2, TRAF3, TRAF6 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_043708 {REF} {Length: 2314} {Pfam: TRAF-type zinc finger [PF02176.20, score=41.5]; Seven in absentia protein family [PF03145.18, score=23.6]} {Human: ENSG00000131323, TRAF3, TNF receptor associated factor 3, [Score=161, Expect=1e-41]} {Mouse: ENSMUSG00000021277, Traf3, TNF receptor-associated factor 3, [Score=158, Expect=6e-41]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=83.6, Expect=1e-16]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=69.3, Expect=4e-12]} {Smed: dd_Smed_v6_168_0_1, dd_Smed_v6_168_0_1, [Score=103, Expect=2e-23]} {RNA1509_50896} {RNA1310_6468} {RNA815_1472} Mlig455_043796 {REF} {Length: 4177} {TRANSSPLICED} {Pfam: COG (conserved oligomeric Golgi) complex component, COG2 [PF06148.13, score=104.6]; Domain of unknown function (DUF3510) [PF12022.10, score=94.3]; TRAF-type zinc finger [PF02176.20, score=30.8]} {Human: ENSG00000135775, COG2, component of oligomeric golgi complex 2, [Score=280, Expect=6e-80]} {Mouse: ENSMUSG00000031979, Cog2, component of oligomeric golgi complex 2, [Score=274, Expect=5e-78]} {Dmel: FBgn0026634, ldlCp, ldlCp-related protein, [Score=196, Expect=5e-52]} {Celegans: WBGene00000585, cogc-2, Conserved oligomeric Golgi complex subunit 2, [Score=132, Expect=3e-31]} {Smed: dd_Smed_v6_5210_0_1, dd_Smed_v6_5210_0_1, [Score=276, Expect=9e-79]} {RNA1509_17078} {RNA1310_5891} {RNA815_1472} Mlig455_047447 {REF} {Length: 1314} {TRANSSPLICED} {Pfam: TRAF-type zinc finger [PF02176.20, score=34.2]; Seven in absentia protein family [PF03145.18, score=19.2]} {Human: ENSG00000175104, TRAF6, TNF receptor associated factor 6, [Score=96.7, Expect=4e-21]} {Mouse: ENSMUSG00000027164, Traf6, TNF receptor-associated factor 6, [Score=90.9, Expect=2e-19]} {Smed: dd_Smed_v6_168_0_1, dd_Smed_v6_168_0_1, [Score=100, Expect=4e-23]} {RNA1509_12449} {RNA1310_8751} {RNA815_1472} |
68. | MligTC455_44444 | 123 | 2.57 | Mlig455_062758 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_062758 {REF} {Length: 1304} {Pfam: Retinal tissue protein [PF10044.11, score=28.1]} {RNA1509_3524} {RNA1310_10649.1} {RNA815_4708.1} | |
69. | MligTC455_45050 | 55 | 1.14 | Mlig455_067805 | Neo: - Age: - |
ADSL | 0.973 | - | - | 0.973 | - | - | - | Mlig455_067805 {REF} {Length: 3003} {TRANSSPLICED} {Pfam: Lyase [PF00206.22, score=80.8]} {Human: ENSG00000239900, ADSL, adenylosuccinate lyase, [Score=447, Expect=2e-155]} {Mouse: ENSMUSG00000022407, Adsl, adenylosuccinate lyase, [Score=446, Expect=3e-155]} {Dmel: FBgn0038467, AdSL, Adenylosuccinate Lyase, [Score=431, Expect=1e-148]} {Celegans: WBGene00011064, adsl-1, Adenylosuccinate lyase, [Score=314, Expect=2e-104]} {Smed: dd_Smed_v6_2280_0_1, dd_Smed_v6_2280_0_1, [Score=416, Expect=4e-143]} {RNA1509_16456} {RNA1310_14851} {RNA815_12501} |
70. | MligTC455_47574 | 716 | 14.92 | Mlig455_028318, Mlig455_066192 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.060 Region-enriched R2: 1.667/0.01738 |
MAN1C1 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962} Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962} |
71. | MligTC455_19695 | 59 | 1.23 | Mlig455_067848 | Neo: - Age: logFC(26M/2M)=-0.595 |
0.972 | - | - | - | - | 0.972 | - | Mlig455_067848 {REF} {Length: 1979} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=32.9]} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=76.3, Expect=8e-16]} {RNA1509_37281} {RNA1310_6533.1} {RNA815_6407} | |
72. | MligTC455_20828 | 43 | 0.91 | Mlig455_039990 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_039990 {REF} {Length: 3053} {NoTransDecoderORF} {RNA1310_18595} {RNA815_11725} | |
73. | MligTC455_15053 | 12 | 0.26 | Mlig455_016326 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053} | |
74. | MligTC455_38926 | 75 | 1.56 | Mlig455_036654 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_036654 {REF} {Length: 654} {TRANSSPLICED} {RNA1509_25556} {RNA1310_11387.2} {RNA815_48752} | |
75. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
76. | MligTC455_43525 | 62 | 1.29 | Mlig455_041078 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_041078 {REF} {Length: 3896} {RNA1509_39963} {RNA1310_38466} {RNA815_23614} | |
77. | MligTC455_20571 | 72 | 1.5 | Mlig455_016577, Mlig455_035609 | Neo: - |
IRX6 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_016577 {REF} {Length: 1698} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=127, Expect=4e-33]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=121, Expect=6e-31]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=123, Expect=8e-32]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=121, Expect=5e-31]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=120, Expect=1e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=118, Expect=1e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=117, Expect=2e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=122, Expect=7e-31]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=9e-35]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} Mlig455_035609 {REF} {Length: 3012} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=125, Expect=1e-32]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSG00000176842, IRX5, iroquois homeobox 5, [Score=119, Expect=4e-30]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=122, Expect=2e-31]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=119, Expect=3e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=117, Expect=2e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=116, Expect=3e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=121, Expect=1e-30]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=2e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=1e-34]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} |
78. | MligTC455_31082 | 93 | 1.93 | Mlig455_020193 | Neo: - Age: Up-Down-Up |
0.97 | - | - | - | - | 0.970 | - | Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1} | |
79. | MligTC455_40204 | 348 | 7.24 | Mlig455_064913, Mlig455_066843 | Neo: - Age: logFC(26M/2M)=-0.350 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_064913 {REF} {Length: 1143} {NoTransDecoderORF} {RNA1509_52747} {RNA1310_89294} {RNA815_41786} Mlig455_066843 {REF} {Length: 633} {NoTransDecoderORF} {RNA1310_106751} {RNA815_41786} |
|
80. | MligTC455_47244 | 216 | 4.49 | Mlig455_016130 | Neo: - Age: - Region-enriched R2: 3.391/0.02151 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_016130 {REF} {Length: 3312} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=27.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.5]} {Smed: dd_Smed_v6_24733_0_1, dd_Smed_v6_24733_0_1, [RH, Score=231, Expect=1e-71]} {RNA1509_41111} {RNA1310_18481.1} {RNA815_10445} | |
81. | MligTC455_49875 | 59 | 1.22 | Mlig455_027217 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_027217 {REF} {Length: 1809} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.9]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=64.7, Expect=5e-12]} {Celegans: WBGene00008997, lgc-31, Ligand-Gated ion Channel, [Score=70.9, Expect=3e-14]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=67.0, Expect=6e-13]} {RNA1310_26175} {RNA815_7952} | |
82. | MligTC455_05979 | 11 | 0.23 | Mlig455_067718 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} | |
83. | MligTC455_43783 | 8 | 0.17 | Mlig455_018589 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]} | |
84. | MligTC455_14604 | 21 | 0.43 | Mlig455_014269 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_014269 {REF} {Length: 2720} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=90.5]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=108, Expect=3e-25]} {RNA1310_19428.1} {RNA815_22602} | |
85. | MligTC455_30826 | 98 | 2.04 | Mlig455_047664 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_047664 {REF} {Length: 879} {NoTransDecoderORF} {RNA1310_39208} {RNA815_16462} | |
86. | MligTC455_26562 | 51 | 1.05 | Mlig455_003821 | Neo: - Age: - Region-enriched R4: 4.788/0.04787 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255} | |
87. | MligTC455_02917 | 13 | 0.26 | Mlig455_071074 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_071074 {REF} {Length: 208} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_14869} {RNA1310_70688} | |
88. | MligTC455_08753 | 8 | 0.16 | Mlig455_038622 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_038622 {REF} {Length: 2031} {RNA1509_4722} {RNA1310_2185} {RNA815_335.3} | |
89. | MligTC455_56572 | 7 | 0.15 | Mlig455_055432 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_055432 {REF} {Length: 280} {NoTransDecoderORF} {RNA1509_59493} {RNA1310_14118} {RNA815_4477.2} | |
90. | MligTC455_57386 | 3 | 0.05 | Mlig455_029469 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_029469 {REF} {Length: 274} {NoTransDecoderORF} {RNA1310_8704.2} | |
91. | MligTC455_00407 | 9 | 0.18 | Mlig455_056959 | Neo: - Age: - |
0.964 | 0.964 | - | - | - | - | - | Mlig455_056959 {REF} {Length: 74} {NoTransDecoderORF} {RNA1509_7205} {RNA1310_35435} {RNA815_6877.1} | |
92. | MligTC455_12059 | 25 | 0.52 | Mlig455_022731 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_022731 {REF} {Length: 1634} {NoTransDecoderORF} {RNA1310_68443} | |
93. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
94. | MligTC455_34534 | 168 | 3.5 | Mlig455_049250 | Neo: - Age: - |
LITAF | 0.963 | 0.963 | - | - | - | - | - | Mlig455_049250 {REF} {Length: 1099} {Pfam: LITAF-like zinc ribbon domain [PF10601.11, score=78.4]; SprT-like zinc ribbon domain [PF17283.4, score=19.2]} {Human: ENSG00000189067, LITAF, lipopolysaccharide induced TNF factor, [Score=75.1, Expect=8e-18]} {Mouse: ENSMUSG00000022500, Litaf, LPS-induced TN factor, [Score=79.0, Expect=2e-19]} {Smed: dd_Smed_v6_26606_0_1, dd_Smed_v6_26606_0_1, [Score=74.3, Expect=9e-19]} {RNA1509_59268} {RNA1310_31303} {RNA815_15626.1} |
95. | MligTC455_36184 | 21 | 0.44 | Mlig455_047420 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_047420 {REF} {Length: 487} {NoTransDecoderORF} {RNA1509_14659} {RNA1310_107234} {RNA815_14343.7} | |
96. | MligTC455_44282 | 3 | 0.06 | Mlig455_068985 | Neo: - Age: - |
ANPEP | 0.963 | - | - | - | - | 0.963 | - | Mlig455_068985 {REF} {Length: 1117} {Pfam: ERAP1-like C-terminal domain [PF11838.10, score=181.0]} {Human: ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=112, Expect=3e-26]} {Mouse: ENSMUSG00000039062, Anpep, alanyl (membrane) aminopeptidase, [Score=107, Expect=1e-24]} {Dmel: FBgn0285963, CG46339, [Score=108, Expect=1e-25]} {Celegans: WBGene00011587, T07F10.1, Aminopeptidase, [Score=92.4, Expect=4e-20]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=122, Expect=3e-30]} {RNA1509_36678} {RNA1310_29849} {RNA815_4134} |
97. | MligTC455_52462 | 166 | 3.45 | Mlig455_005943 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=4.076 Regeneration-upregulated R2: 5.759 Regeneration-enriched R2: 5.759 |
AGRN | 0.963 | - | - | - | - | 0.963 | - | Mlig455_005943 {REF} {Length: 1577} {Pfam: Kazal-type serine protease inhibitor domain [PF00050.23, score=130.4]; Kazal-type serine protease inhibitor domain [PF07648.17, score=91.6]} {Human: ENSG00000188157, AGRN, agrin, [Score=55.8, Expect=8e-08]} {Mouse: ENSMUSG00000041936, Agrn, agrin, [Score=56.2, Expect=4e-08]} {Dmel: FBgn0052354, CG32354, [Score=48.1, Expect=9e-06]} {Smed: dd_Smed_v6_3649_0_1, dd_Smed_v6_3649_0_1, [Score=51.6, Expect=5e-07]} {RNA1509_43736} {RNA1310_19594} {RNA815_11515} |
98. | MligTC455_28646 | 3 | 0.07 | Mlig455_034581 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_034581 {REF} {Length: 2541} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF389) [PF04087.16, score=95.3]} {Dmel: FBgn0083945, CG34109, [RH, Score=160, Expect=1e-40]} {Smed: dd_Smed_v6_9934_0_1, dd_Smed_v6_9934_0_1, [RH, Score=151, Expect=2e-38]} {RNA1509_24637} {RNA1310_8899} {RNA815_11179} | |
99. | MligTC455_56179 | 4 | 0.09 | Mlig455_008430 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_008430 {REF} {Length: 350} {NoTransDecoderORF} | |
100. | MligTC455_56840 | 7 | 0.15 | Mlig455_012947 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_012947 {REF} {Length: 4} {NoTransDecoderORF} |